BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27398769)

  • 1. Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy.
    Johnson SC
    Top Antivir Med; 2016 Dec-2017 Jan; 23(5):161-7. PubMed ID: 27398769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational Agents.
    Gulick RM
    Top Antivir Med; 2015; 23(4):128-31. PubMed ID: 26713502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
    Hammer SM; Eron JJ; Reiss P; Schooley RT; Thompson MA; Walmsley S; Cahn P; Fischl MA; Gatell JM; Hirsch MS; Jacobsen DM; Montaner JS; Richman DD; Yeni PG; Volberding PA;
    JAMA; 2008 Aug; 300(5):555-70. PubMed ID: 18677028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral therapy of HIV infection].
    Imamura A
    Nihon Rinsho; 2012 Apr; 70(4):601-6. PubMed ID: 22568140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to start antiretroviral therapy.
    Kitahata MM
    Top HIV Med; 2010; 18(3):121-6. PubMed ID: 20921578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Geffen N; Aagaard P; Corbelli GM; Meulbroek M; Peavy D; Rappoport C; Schwarze S; Collins S;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):10-3. PubMed ID: 25711318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India.
    Chadha S; Bhalla P; Jha AK; Gautam H; Saini S; Anuradha S; Dewan R
    J Infect Dev Ctries; 2013 Feb; 7(2):110-5. PubMed ID: 23416656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    Lodi S; Sharma S; Lundgren JD; Phillips AN; Cole SR; Logan R; Agan BK; Babiker A; Klinker H; Chu H; Law M; Neaton JD; Hernán MA;
    AIDS; 2016 Nov; 30(17):2659-2663. PubMed ID: 27782964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rating evidence in treatment guidelines: a case example of when to initiate combination antiretroviral therapy (cART) in HIV-positive asymptomatic persons.
    Sabin CA; Cooper DA; Collins S; Schechter M
    AIDS; 2013 Jul; 27(12):1839-46. PubMed ID: 24179998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of the 2014 International AIDS Conference: update from down under.
    Volberding PA
    Top Antivir Med; 2014 Dec-2015 Jan; 22(5):694-7. PubMed ID: 25612178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antiretroviral therapy.
    Olender S; Wilkin TJ; Taylor BS; Hammer SM
    Top Antivir Med; 2012; 20(2):61-86. PubMed ID: 22710908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?
    Rodger AJ; Sabin CA
    Curr Opin HIV AIDS; 2016 Sep; 11(5):487-491. PubMed ID: 27465878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current use of antiretroviral treatment.
    Bailey AC; Fisher M
    Br Med Bull; 2008; 87():175-92. PubMed ID: 18757468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.